This World Allergy Week (April 22 - 28) and World Asthma Day (May 1), Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is helping parents take charge of their children's asthma and allergy symptoms through awareness initiatives in more than 20 countries worldwide. 
The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic retinopathy occurs when high levels of blood sugar lead to damage in the blood vessels of the retina, the light-sensitive tissue in the back of the eye. 
The European Innovation Council (EIC) SME Instrument and Roche invite you to pitch your ideas and breakthroughs on healthcare tech at the Roche Innovation Summit on the 19th and 20th of June in Basel, Switzerland. On a yearly basis, Roche organises an internal Innovation summit, to inspire, connect, develop and advance their organisation. Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, together with its consortium partners, today announced that it has received funding from the EU's Horizon 2020 program to pilot big data solutions to achieve better patient outcomes in healthcare at a lower cost. 
Merck, a leading science and technology company, today announced a new collaboration with US-based Medisafe to help its cardiometabolic patients better manage medication intake and adhere to prescribed treatment regimens. In the countries of scope Merck patients will have access to a customized version of Medisafe's mobile platform that could combine reminders, motivation and support systems, targeted content, coupons and interventions in their local language. Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH), both members of the Partners HealthCare network, will implement the Philips IntelliSite Pathology Solution [1] to enable research and support clinical diagnosis. 
WhatsApp, Facebook Messenger and other unauthorised instant messaging (IM) apps are being used by approximately 500,000 NHS staff at work, as a growing number turn to consumer tools to communicate with colleagues and even patients, a new report has revealed.